Triumeq and Paraesthesia - a phase IV clinical study of FDA data

Summary:

Paraesthesia is reported as a side effect among people who take Triumeq (abacavir sulfate; dolutegravir sodium; lamivudine), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Tivicay, and have Tuberculosis.

The phase IV clinical study analyzes which people have Paraesthesia when taking Triumeq. It is created by eHealthMe based on reports of 6,839 people who have side effects when taking Triumeq from the FDA, and is updated regularly.

What is Triumeq?

Triumeq has active ingredients of abacavir sulfate; dolutegravir sodium; lamivudine. It is often used in hiv infection. eHealthMe is studying from 6,900 Triumeq users. Check the latest studies of Triumeq.

What is Paraesthesia?

Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect) is found to be associated with 2,690 drugs and 3,120 conditions by eHealthMe. Check the latest studies of Paraesthesia.

On Aug, 10, 2026

6,839 people reported to have side effects when taking Triumeq.
Among them, 51 people (0.75%) have Paraesthesia.

Among these 51 people:

How long have people been on Triumeq when they have Paraesthesia? *

What is the gender of people who have Paraesthesia when taking Triumeq? *

female: 21.74 %
male: 78.26 %

What is the age of people who have Paraesthesia when taking Triumeq? *

What are other drugs people take besides Triumeq? *

What are other side effects people have besides Paraesthesia? *

Headache (pain in head): 16 people, 31.37%
Fatigue (feeling of tiredness): 11 people, 21.57%
Loss Of Consciousness: 9 people, 17.65%
Pain: 9 people, 17.65%
Ill-Defined Disorder: 9 people, 17.65%
Malaise (a feeling of general discomfort or uneasiness): 9 people, 17.65%
Muscle Aches (muscle pain): 8 people, 15.69%
Stress And Anxiety: 8 people, 15.69%
Chest Pain: 8 people, 15.69%
Dysstasia (difficulty in standing): 8 people, 15.69%

What are the existing conditions these people have? *

Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 7 people, 13.73%
Tuberculoma Of Central Nervous System (a tumour-like mass that is not a cancer in brain, a complication of tuberculosis): 3 people, 5.88%
Malaria (a parasitic disease due to mosquito bite): 3 people, 5.88%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 3 people, 5.88%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 1.96%
Nausea (feeling of having an urge to vomit): 1 person, 1.96%
Migraine (headache): 1 person, 1.96%
Hyperchlorhydria (gastric acid levels are higher in stomach): 1 person, 1.96%
High Blood Pressure: 1 person, 1.96%
Dyspnea (difficult or laboured breathing): 1 person, 1.96%

* Approximation only. Some reports may have incomplete information.

Do you take Triumeq and have Paraesthesia?

- Check whether Paraesthesia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Triumeq:

Triumeq (6,900 reports)

Paraesthesia treatments and more:

Paraesthesia (184,215 reports)

How severe was Paraesthesia and when was it recovered:

Paraesthesia in Triumeq

Expand to all the drugs that have ingredients of abacavir sulfate; dolutegravir sodium; lamivudine:

Paraesthesia and drugs with ingredients of abacavir sulfate; dolutegravir sodium; lamivudine

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Triumeq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paraesthesia:

Paraesthesia (2,690 drugs)

Browse all the conditions that are associated with Paraesthesia:

Paraesthesia (3,120 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abacavir sulfate; dolutegravir sodium; lamivudine (the active ingredients of Triumeq) and Triumeq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.